Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$66.18 - $82.86 $563,324 - $705,304
-8,512 Reduced 0.64%
1,317,886 $87.8 Million
Q2 2022

Aug 15, 2022

SELL
$66.18 - $83.18 $4.69 Million - $5.89 Million
-70,867 Reduced 5.07%
1,326,398 $101 Million
Q1 2022

May 16, 2022

SELL
$66.02 - $79.71 $176 Million - $212 Million
-2,661,792 Reduced 65.58%
1,397,265 $111 Million
Q4 2021

Feb 14, 2022

SELL
$63.34 - $74.11 $4.47 Million - $5.23 Million
-70,621 Reduced 1.71%
4,059,057 $298 Million
Q3 2021

Nov 15, 2021

BUY
$68.67 - $84.02 $2.28 Million - $2.79 Million
33,174 Added 0.81%
4,129,678 $284 Million
Q2 2021

Aug 16, 2021

SELL
$79.87 - $87.53 $112 Million - $123 Million
-1,406,131 Reduced 25.55%
4,096,504 $345 Million
Q1 2021

May 14, 2021

SELL
$76.02 - $100.5 $97.9 Million - $129 Million
-1,287,178 Reduced 18.96%
5,502,635 $447 Million
Q4 2020

Feb 12, 2021

SELL
$80.74 - $97.7 $48.5 Million - $58.7 Million
-600,310 Reduced 8.12%
6,789,813 $591 Million
Q3 2020

Nov 13, 2020

SELL
$85.07 - $109.69 $138 Million - $178 Million
-1,619,297 Reduced 17.97%
7,390,123 $663 Million
Q2 2020

Aug 14, 2020

SELL
$74.18 - $108.93 $34 Million - $50 Million
-458,755 Reduced 4.85%
9,009,420 $937 Million
Q1 2020

May 15, 2020

SELL
$63.18 - $85.97 $2.01 Million - $2.74 Million
-31,815 Reduced 0.33%
9,468,175 $693 Million
Q4 2019

Feb 18, 2020

BUY
$73.04 - $95.72 $27.5 Million - $36 Million
376,113 Added 4.12%
9,499,990 $830 Million
Q3 2019

Nov 14, 2019

BUY
$72.82 - $86.52 $10 Million - $11.9 Million
137,466 Added 1.53%
9,123,877 $677 Million
Q2 2019

Aug 14, 2019

BUY
$73.52 - $88.7 $87.1 Million - $105 Million
1,184,504 Added 15.18%
8,986,411 $763 Million
Q1 2019

May 15, 2019

BUY
$63.56 - $88.17 $10.4 Million - $14.4 Million
163,505 Added 2.14%
7,801,907 $671 Million
Q4 2018

Feb 14, 2019

BUY
$58.5 - $69.94 $4 Million - $4.78 Million
68,385 Added 0.9%
7,638,402 $486 Million
Q3 2018

Nov 14, 2018

SELL
$61.75 - $74.23 $31.4 Million - $37.8 Million
-508,630 Reduced 6.3%
7,570,017 $523 Million
Q2 2018

Aug 14, 2018

BUY
$60.85 - $83.98 $44.7 Million - $61.6 Million
733,970 Added 9.99%
8,078,647 $541 Million
Q1 2018

May 15, 2018

BUY
$83.06 - $100.98 $11.5 Million - $14 Million
138,698 Added 1.92%
7,344,677 $612 Million
Q4 2017

Feb 14, 2018

BUY
$93.56 - $116.6 $66.6 Million - $83 Million
711,413 Added 10.95%
7,205,979 $682 Million
Q3 2017

Nov 14, 2017

BUY
$109.15 - $138.27 $709 Million - $898 Million
6,494,566
6,494,566 $758 Million

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $16B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Capital International Investors Portfolio

Follow Capital International Investors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital International Investors, based on Form 13F filings with the SEC.

News

Stay updated on Capital International Investors with notifications on news.